Mfd. by :- (Fulfilled By : Magicine Pharma)
Magicine Pharma is registered with the Government Of NCT, India, Ministry Of Health in Government of Delhi, India, registration number DL-RAJ-122372 and as a wholesale distributor, department file No. 44208.
Name: Chikungunya (IgM/IgG)
Usage: To detect the Chikungunya virus
Manufacturer: BioSci healthcare
Individually sealed foil pouches contain:
One cassette device
One desiccant
Capillary tubes (5 μL)
Sample diluent (REF SB-R0066, 5 mL/bottle)
One package insert (instructions)
This test is used to diagnose recent infections with the Chikungunya virus in suspected patients (showing symptoms) or patients who have traveled to endemic areas. Sometimes repeat testing is done after an interval of a few days to confirm the results.
0.79 or less - No significant levels of Chikungunya IgM antibody
0.80 – 1.09 - Possible presence of Chikungunya IgM antibody. Repeat testing is required.
1.10 or greater - Definite indication for the presence of chikungunya IgM antibody.
Sensitivity: 90.4%
Specificity: 98.0%
This qualitative test helps in detecting the presence of the chikungunya virus in human serum, whole blood, and plasma. Chikungunya (IgM/IgG) test is the most practical lab method that helps in distinguishing the infection present with similar symptoms. This test also helps in detecting recent or past infections with the chikungunya virus in patients. Chikungunya test determines the presence of IgG and IgM antibodies. The detection limit of the virus is compared with the referral range to find out the value of the collective sample.
Q1. What is Chikungunya (IgM/IgG)?
Ans. This test helps in detecting the presence of the chikungunya virus in human serum, whole blood, and plasma. The repetition of testing is also recommended to confirm the results.
Q2. Who performs this procedure?
Ans. The procedure of the Chikungunya (IgM/IgG) is performed by lab technicians to manage the complications and risks associated with it.
Q3. What is the clinical performance of Chikungunya (IgM/IgG)?
Ans. The clinical performance of Chikungunya (IgM/IgG) is Sensitivity: 90.4% and Specificity: 98.0%.